Dasatinib as first-line treatment for adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia

Overview of attention for article published in Blood, September 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

So far, Altmetric has seen 1 news story.

5 min read Source/Disclosures Disclosures: Short reports honoraria from Amgen, as well as consultant roles with AstraZeneca and…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.